Category: coronavirus
Leak exposes personal data for millions of Brazilian COVID-19 patients
Medical data breaches are serious as a rule, but an incident in Brazil may be particularly severe. According to ZDNet, Brazilian newspaper Estadao has learned that a Sao Paolo hospital worker uploaded a spreadsheet with login details for two governme… Source
Read More
Amazon will give its US frontline workers a $300 holiday bonus
Amazon plans to give its frontline employees who help it through the busy holiday shopping season a special bonus (via CNET). The company will give full-time US employees who work December 1st through to December 31st an extra $300 at the end of the… Source
Read More
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 clinical trial was actually administered by accident. AstraZeneca and its partner the University of Oxford…
Read More
FDA clears emergency use of lab-made antibodies to treat COVID-19
The FDA just cleared a medical advance that could play an important (if limited) role in treating COVID-19 patients. The administration has granted emergency use authorization for Regeneron’s lab-made monoclonal antibodies (a combo of casirivimab and… Source
Read More
Facebook, Google and Twitter brace for coronavirus vaccine misinformation
Facebook, Twitter and Google are gearing up for the next big misinformation fight. The companies are joining forces with fact checkers and government agencies from around the world to combat misinformation about the upcoming coronavirus vaccines. Und… Source
Read More
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a…
Read More